Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma
Johann von Felden, Amanda J. Craig, Teresa García‐Lezana, Ismaïl Labgaa, Philipp K. Haber, Delia D’Avola, Amon Asgharpour, Douglas T. Dieterich, Antoinette Bonaccorso, Miguel Torres‐Martín, Daniela Sia, Max W. Sung, Parissa Tabrizian, Myron Schwartz, Josep M. Llovet, Augusto Villanueva
Topics & Concepts
PTENHepatocellular carcinomaBiologyCancer researchInternal medicineOncologyProgression-free survivalMutationPI3K/AKT/mTOR pathwayGeneMedicineOverall survivalGeneticsSignal transductionCancer Genomics and DiagnosticsHepatocellular Carcinoma Treatment and PrognosisLung Cancer Treatments and Mutations